Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 810-817

  Talvas, J ^a,b   Garrait, G ^a,b   Goncalves Mendes, N ^a,b   Rouanet, J ^a,b   Vergnaud Gauduchon, J ^a,b   Kwiatkowski, F ^c   Bachmann, P ^d   Bouteloup, C ^a,b,e   Bienvenu, J ^f   Vasson, M P ^a,b,e  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CRNH AUVERGNE   (France)

^c CENTRE JEAN PERRIN   (France)

^d CENTRE LÉON BÉRARD   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Cancer; Immunonutrition; Radiochemotherapy

Indexed keywords

CD15 ANTIGEN; L SELECTIN; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ANTIOXIDANT; ARGININE; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MESSENGER RNA; TRANSCRIPTOME;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL METABOLISM; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; ENZYME SYNTHESIS; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATING ENTERAL NUTRITION; IMMUNONUTRITION; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MULTICENTER STUDY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 2 CLINICAL TRIAL; POLYMORPHONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; AGED; BLOOD; BLOOD CELL COUNT; CLINICAL TRIAL; DRUG EFFECTS; ENTERIC FEEDING; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENETICS; IMMUNOMODULATION; LENGTH OF STAY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; NUTRITIONAL STATUS; POSTOPERATIVE CARE; PROCEDURES;

AGED; ANTIOXIDANTS; ARGININE; BIOMARKERS; BLOOD CELL COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMORADIOTHERAPY; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOMODULATION; LENGTH OF STAY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUTRITIONAL STATUS; POSTOPERATIVE CARE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84939267634     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.12.002     Document Type: Article

References (34)

1. Choong N., Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 2008 Jan-Feb, 58(1):32-53.
2. Campbell N.P., Villaflor V.M. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 2010 Aug 14, 16(30):3793-3803.
3. Heidecke C.D., Weighardt H., Feith M., Fink U., Zimmermann F., Stein H.J., et al. Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy. Surgery 2002 Sep, 132(3):495-501.
4. Kubrak C., Olson K., Jha N., Scrimger R., Parliament M., McCargar L., et al. Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view. Head Neck 2013 May, 35(5):695-703.
5. Langer C.J., Hoffman J.P., Ottery F.D. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition 2001 Jan, 17(1 Suppl.):S1-S20.
6. Braga M., Wischmeyer P.E., Drover J., Heyland D.K. Clinical evidence for pharmaconutrition in major elective surgery. JPEN J Parenter Enternal Nutr 2013 Sep, 37(5 Suppl.):66S-72S.
7. Sorensen D., McCarthy M., Baumgartner B., Demars S. Perioperative immunonutrition in head and neck cancer. Laryngoscope 2009 Jul, 119(7):1358-1364.
8. Riso S., Aluffi P., Brugnani M., Farinetti F., Pia F., D'Andrea F. Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr 2000 Dec, 19(6):407-412.
9. Vasson M.P., Talvas J., Perche O., Dillies A.F., Bachmann P., Pezet D., et al. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. Clin Nutr 2014 Apr, 33(2):204-210.
10. Machon C., Thezenas S., Dupuy A.M., Assenat E., Michel F., Mas E., et al. Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer 2012 Dec, 20(12):3129-3135.
11. Sunpaweravong S., Puttawibul P., Ruangsin S., Laohawiriyakamol S., Sunpaweravong P., Sangthawan D., et al. Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. Nutr Cancer 2014 Jan, 66(1):1-5.
12. Yoshida S., Matsui M., Shirouzu Y., Fujita H., Yamana H., Shirouzu K. Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer. Ann Surg 1998 Apr, 227(4):485-491.
13. Takagi K., Yamamori H., Furukawa K., Miyazaki M., Tashiro T. Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. Nutrition 2001 Jun, 17(6):478-479.
14. Shintani Y., Ikeda N., Matsumoto T., Kadota Y., Okumura M., Ohno Y., et al. Nutritional status of patients undergoing chemoradiotherapy for lung cancer. Asian Cardiovasc Thorac Ann 2012 Apr, 20(2):172-176.
15. Kwiatkowski F., Girard M., Hacene K., Berlie J. Sem: a suitable statistical software adapted for research in oncology. Bull Cancer 2000 Oct, 87(10):715-721.
16. Tardy A.L., Giraudet C., Rousset P., Rigaudiere J.P., Laillet B., Chalancon S., et al. Effects of trans MUFA from dairy and industrial sources on muscle mitochondrial function and insulin sensitivity. J Lipid Res 2008 Jul, 49(7):1445-1455.
17. Farges M.C., Minet-Quinard R., Walrand S., Thivat E., Ribalta J., Winklhofer-Roob B., et al. Immune status is more affected by age than by carotenoid depletion-repletion in healthy human subjects. Br J Nutr 2012 Mar 8, 1-12.
18. Allegra S., Deleine C., Michael-Jubely R., Gryson C., Boirie Y., Kantakamalakul W., et al. Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding. Cytom A 2006 Sep 1, 69(9):992-998.
19. Merlin E., Goncalves-Mendes N., Hannani D., de la Torre A., Farges M.C., Laroye H., et al. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. Transpl Immunol 2011 Jan 15, 24(2):100-106.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001 Dec, 25(4):402-408.
21. Zea A.H., Rodriguez P.C., Culotta K.S., Hernandez C.P., DeSalvo J., Ochoa J.B., et al. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol 2004 Nov-Dec, 232(1-2):21-31.
22. Tedder T.F., Steeber D.A., Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995 Jun 1, 181(6):2259-2264.
23. Kerr M.A., Stocks S.C. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem J 1992 Nov, 24(11):811-826.
24. Calder P.C., Dangour A.D., Diekman C., Eilander A., Koletzko B., Meijer G.W., et al. Essential fats for future health. Proceedings of the 9th Unilever Nutrition Symposium, 26-27 May 2010. Eur J Clin Nutr 2010 Dec, 64(Suppl. 4):S1-S13.
25. Lamas B., Vergnaud-Gauduchon J., Goncalves-Mendes N., Perche O., Rossary A., Vasson M.P., et al. Altered functions of natural killer cells in response to L-Arginine availability. Cell Immunol 2012 Dec, 280(2):182-190.
26. Norris P.C., Dennis E.A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc Natl Acad Sci U S A 2012 May 29, 109(22):8517-8522.
27. Bernal M., Ruiz-Cabello F., Concha A., Paschen A., Garrido F. Implication of the beta2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother 2012 Sep, 61(9):1359-1371.
28. Braicu E.I., Gasimli K., Richter R., Nassir M., Kummel S., Blohmer J.U., et al. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer-results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial. Anticancer Res 2014 Jan, 34(1):385-391.
29. Pan L., Baek S., Edmonds P.R., Roach M., Wolkov H., Shah S., et al. Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610. Radiat Oncol 2013 Apr, 25(8):100.
30. Durken M., Herrnring C., Finckh B., Nagel S., Nielsen P., Fischer R., et al. Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 2000 Mar 15, 28(6):887-894.
31. Rossary A., Arab K., Steghens J.P. Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts. Biochem J 2007 Aug 15, 406(1):77-83.
32. Ueno C., Fukatsu K., Maeshima Y., Moriya T., Omata J., Saitoh D., et al. Arginine-enriched total parenteral nutrition improves survival in peritonitis by normalizing NFkappaB activation in peritoneal resident and exudative leukocytes. Ann Surg 2010 May, 251(5):959-965.
33. Lecleire S., Hassan A., Marion-Letellier R., Antonietti M., Savoye G., Bole-Feysot C., et al. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 2008 Dec, 138(12):2481-2486.
34. Weise C., Hilt K., Milovanovic M., Ernst D., Ruhl R., Worm M. Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFkappaB pathway in human B cells. J Nutr Biochem 2011 Mar, 22(3):269-275.